Prollenium Medical Technologies Inc 138 Industrial Parkway Northaurora L4g 4 Pma Numberp160042 Supplement Numbers017 Date Received10 05 2021 Decision Date04 20 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type135 Review Track For 30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Prollenium Medical Technologies Inc 138 Industrial Parkway Northaurora L4g 4 Pma Numberp160042 Supplement Numbers017 Date Received10 05 2021 Decision Date04 20 2022 Product Code Lmh Advisory Committee General Plastic Surgery Supplement Type135 Review Track For 30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
PROLLENIUM MEDICAL TECHNOLOGIES INC.138 Industrial Parkway Northaurora L4G 4 PMA NumberP160042 Supplement NumberS017 Date Received10/05/2021 Decision Date04/20/2022 Product Code LMH  Advisory Committee General & Plastic Surgery Supplement Type135 Review Track For 30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
Revanesse Versa+ with Lidocaine (1.0 mL and 1.2 mL) and Revanesse Lips+ with Lidocaine (1.0 mL and 1.2 mL)2022-04-20

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.